{"id":"NCT02251431","sponsor":"Baylor Research Institute","briefTitle":"Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome","officialTitle":"MB001-067 A PROSPECTIVE, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, RANDOMIZED TRIAL OF EXTENDED RELEASE EXENATIDE VERSUS PLACEBO (COHORT A) AND A PROSPECTIVE, SINGLE GROUP, OPEN-LABEL, BLINDED OUTCOME TRIAL OF EXTENDED RELEASE EXENATIDE (COHORT B) IN DIABETIC PATIENTS WITH TYPE 4 CARDIORENAL SYNDROME (EXTEND-CRS TRIAL) AMENDMENT 3","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11","primaryCompletion":"2019-12","completion":"2019-12","firstPosted":"2014-09-29","resultsPosted":"2023-05-17","lastUpdate":"2023-05-17"},"enrollment":57,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus","Chronic Kidney Disease","Left Ventricular Diastolic Dysfunction"],"interventions":[{"type":"DRUG","name":"BYDUREON","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["Matching placebo subcutaneous injection"]}],"arms":[{"label":"Exenatide-extended release","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Among adult individuals with type 2 diabetes mellitus and at risk for heart failure with impaired relaxation of the heart mildly reduced kidney filtration function (Type 4 cardiorenal syndrome) this trial will evaluate the quantitative impact of 38 weeks of treatment with exenatide extended-release injections versus placebo. on a cardiac biomarker blood test score, cardiac fibrosis seen on magnetic resonance scanning, cardiac strain identified by ultrasonography and strain rate imaging, and a kidney urine biomarker score.","primaryOutcome":{"measure":"Galectin-3","timeFrame":"38 weeks","effectByArm":[{"arm":"Exenatide-extended Release","deltaMin":9570.91,"sd":4990.06},{"arm":"Placebo","deltaMin":9266.7,"sd":6032.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":26},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["17239676","21802579","1080957","20929995","22249510","23482076","20620723"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Gastrointestinal events, myalgia, fatigue","Injection site reaction"]}}